[Federal Register Volume 65, Number 165 (Thursday, August 24, 2000)]
[Notices]
[Page 51595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-21658]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Treatment or 
Prophylaxis of Retinal Pathology and Spinal Cord Injury

AGENCY: U.S. Army Medical Research and Materiel Command, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application Serial Number 09/
133,805 entitled ``Treatment or Prophylaxis of Retinal Pathology and 
Spinal Cord Injury'', filed August 13, 1998. Foreign rights are also 
available. This patent has been assigned to the United States 
Government as represented by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention is related to use of PMPA, 
-NAAG and -NAAG to prevent and treat conditions 
arising from exposure of neuronal tissue to toxins, injury, ischemia 
and hypoxia. Target tissues include the brain, spinal cord and retina.

Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 00-21658 Filed 8-23-00; 8:45 am]
BILLING CODE 3710-08-P